nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00221	0.00221	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00218	0.00218	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00216	0.00216	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00215	0.00215	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00213	0.00213	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00213	0.00213	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00206	0.00206	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00205	0.00205	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00203	0.00203	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00202	0.00202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00198	0.00198	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00198	0.00198	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00196	0.00196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00191	0.00191	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00191	0.00191	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00191	0.00191	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00191	0.00191	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.0019	0.0019	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—SCT—polycystic ovary syndrome	0.0019	0.0019	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00183	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00182	0.00182	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00181	0.00181	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00176	0.00176	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00175	0.00175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NMNAT3—polycystic ovary syndrome	0.00173	0.00173	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0017	0.0017	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0017	0.0017	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00169	0.00169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00168	0.00168	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00164	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00164	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00164	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00163	0.00163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00163	0.00163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00163	0.00163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00159	0.00159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00159	0.00159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LPCAT2—polycystic ovary syndrome	0.00158	0.00158	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SUOX—polycystic ovary syndrome	0.00158	0.00158	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00153	0.00153	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00153	0.00153	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00151	0.00151	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00149	0.00149	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00148	0.00148	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ISYNA1—polycystic ovary syndrome	0.00147	0.00147	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00146	0.00146	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00145	0.00145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00145	0.00145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00145	0.00145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00134	0.00134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00134	0.00134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00133	0.00133	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00132	0.00132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00132	0.00132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00132	0.00132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00131	0.00131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00131	0.00131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00131	0.00131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TEAD2—polycystic ovary syndrome	0.00125	0.00125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKR1C2—polycystic ovary syndrome	0.00125	0.00125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00121	0.00121	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.0012	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.0012	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00119	0.00119	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00118	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NPB—polycystic ovary syndrome	0.00115	0.00115	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00115	0.00115	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00114	0.00114	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00112	0.00112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00112	0.00112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00111	0.00111	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00111	0.00111	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0011	0.0011	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00109	0.00109	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00108	0.00108	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00107	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00105	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00105	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00105	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PNPLA2—polycystic ovary syndrome	0.00105	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00104	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00104	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00104	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00103	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00103	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00103	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00102	0.00102	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00102	0.00102	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00102	0.00102	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000992	0.000992	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000977	0.000977	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000973	0.000973	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000967	0.000967	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000967	0.000967	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000964	0.000964	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000964	0.000964	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—STAR—polycystic ovary syndrome	0.000946	0.000946	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000932	0.000932	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000929	0.000929	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00091	0.00091	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000907	0.000907	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000904	0.000904	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000901	0.000901	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000878	0.000878	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000875	0.000875	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000854	0.000854	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000851	0.000851	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	0.000844	0.000844	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000832	0.000832	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00083	0.00083	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000805	0.000805	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000777	0.000777	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000774	0.000774	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000758	0.000758	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000755	0.000755	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000734	0.000734	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000717	0.000717	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000708	0.000708	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000705	0.000705	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000695	0.000695	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000693	0.000693	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000691	0.000691	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000688	0.000688	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000686	0.000686	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000665	0.000665	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000663	0.000663	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000647	0.000647	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000645	0.000645	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000639	0.000639	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000631	0.000631	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000629	0.000629	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000627	0.000627	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000625	0.000625	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000623	0.000623	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000621	0.000621	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000619	0.000619	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000616	0.000616	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000614	0.000614	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000602	0.000602	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.0006	0.0006	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000597	0.000597	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000583	0.000583	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000582	0.000582	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000581	0.000581	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00058	0.00058	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000577	0.000577	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000575	0.000575	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000573	0.000573	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00057	0.00057	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000568	0.000568	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000566	0.000566	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000563	0.000563	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00055	0.00055	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000549	0.000549	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000541	0.000541	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000539	0.000539	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000536	0.000536	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000535	0.000535	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000535	0.000535	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000534	0.000534	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000532	0.000532	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000528	0.000528	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000526	0.000526	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000526	0.000526	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000501	0.000501	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000499	0.000499	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000494	0.000494	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000492	0.000492	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000472	0.000472	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000471	0.000471	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000456	0.000456	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000449	0.000449	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000447	0.000447	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000443	0.000443	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000442	0.000442	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00044	0.00044	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000437	0.000437	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000436	0.000436	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000417	0.000417	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000406	0.000406	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000406	0.000406	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000405	0.000405	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000405	0.000405	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000392	0.000392	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00039	0.00039	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000388	0.000388	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000386	0.000386	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000378	0.000378	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000377	0.000377	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000376	0.000376	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000375	0.000375	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000372	0.000372	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000358	0.000358	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000357	0.000357	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000356	0.000356	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000355	0.000355	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000354	0.000354	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000354	0.000354	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000353	0.000353	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000342	0.000342	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000341	0.000341	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000336	0.000336	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000336	0.000336	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000335	0.000335	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000313	0.000313	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000312	0.000312	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000311	0.000311	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000297	0.000297	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000296	0.000296	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000292	0.000292	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000291	0.000291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	0.000254	0.000254	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—POMC—polycystic ovary syndrome	0.00025	0.00025	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00025	0.00025	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000249	0.000249	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—INS—polycystic ovary syndrome	0.000249	0.000249	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000245	0.000245	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000244	0.000244	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000218	0.000218	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000217	0.000217	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.00021	0.00021	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000209	0.000209	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000209	0.000209	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	0.000208	0.000208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000201	0.000201	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000201	0.000201	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000192	0.000192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000191	0.000191	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000155	0.000155	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000154	0.000154	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	9.13e-05	9.13e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	9.1e-05	9.1e-05	CbGpPWpGaD
